Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 118.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 187.50
  • 52 Week Low: 92.00
  • Currency: UK Pounds
  • Shares Issued: 84.07m
  • Volume: 4,595
  • Market Cap: £99.62m
  • RiskGrade: 480

Diaceutics begins listed company life on AIM

By Josh White

Date: Thursday 21 Mar 2019

LONDON (ShareCast) - (Sharecast News) - Data analytics and implementation services company Diaceutics confirmed the admission of its entire issued ordinary share capital, which comprises 69,583,077 ordinary shares, to trading on AIM on Thursday morning.
The firm said it successfully raised £17m in gross proceeds, before expenses, through a placing of 22,368,427 new ordinary shares at a price of 76p, through its nominated adviser and broker, Cenkos Securities.

In addition, 4,934,205 existing ordinary shares were placed on behalf of existing shareholders.

Diaceutics said the new ordinary shares represented 32.15% of the company's enlarged share capital on admission.

Its market capitalisation on admission, at the placing price, was £52.9m.

"We are very pleased with the level of interest generated from new institutional investors in support of our admission to trading on AIM," said Diaceutics chief executive officer Peter Keeling.

"The move to AIM and the additional funding will allow us to continue our growth trajectory by developing our product and services offering which is focused on better testing and better treatment in the global pharmaceutical industry."

Keeling said the name Diaceutics reflected the firm's activities at the intersection between diagnostics and pharmaceuticals, as did the ticker it had chosen - DXRX - which was made up of 'Dx', the industry shorthand for a diagnostic, and 'Rx', the one for a prescription drug.

"We would like to thank our new and existing investors for their support, and the whole Diaceutics team for coming with us on this exciting journey."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 118.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 187.50
52 Week Low 92.00
Volume 4,595
Shares Issued 84.07m
Market Cap £99.62m
RiskGrade 480

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.85% below the market average86.85% below the market average86.85% below the market average86.85% below the market average86.85% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average
Price Trend
22.75% above the market average22.75% above the market average22.75% above the market average22.75% above the market average22.75% above the market average
31.58% below the sector average31.58% below the sector average31.58% below the sector average31.58% below the sector average31.58% below the sector average
Income Not Available
Growth
9.96% above the market average9.96% above the market average9.96% above the market average9.96% above the market average9.96% above the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average

Diaceutics Dividends

No dividends found

Trades for 18-Sep-2020

Time Volume / Share Price
16:24 28 @ 118.68p
10:46 328 @ 118.80p
10:25 4,000 @ 117.18p
09:27 239 @ 117.18p

Diaceutics Key Personnel

CEO Peter Keeling
CFO Philip Henry Hugh White

Top of Page